Induced Pluripotent Stem Cells (iPSC) Services

The Waisman Center iPSCService derives iPScell lines for the benefit of stem cell researchers at UW-Madison and beyond.

The development of CRISPR/Cas9 gene editing has altered how stem cell science is done.This technology allows quick and efficient generation of transgenic or isogenic lines for nearly unlimited research purposes that have previously been unfeasible. The Human Stem Cell Gene Editing Service CRISPR/Cas9 genome editing in human pluripotent stem cells.

While we believe every researcher should have access to this technology, individual labs should not have to adopt the technology to reap the rewards. As a core service, we will serve as the experts in generating cell lines so labs can focus on addressing underlying scientific questions.

iPSC Services

  • 6 iPSC clones from each starting sample
  • Mycoplasma testing of initial samples and resultant clones
  • Frozen vials of resultant clones
  • Stem cell marker immunofluorescence
  • WiCell characterization that includes research banking, STR analysis and karyotyping is available to UW researchers

Gene Editing Services

  • Gene mutation correction/induction
  • Endogenous site reporter insertion
  • Safe harbor site reporter insertion
  • Lineage-tracing dual insertion
  • Custom gene editing projects


Leadership & Staff

Su-Chun Zhang, MD, PhD Su-Chun Zhang, MD, PhD
iPSC Service Director
Su-Chun Zhang, MD, PhD iPSC Service Director Anita Bhattacharyya, PhD iPSC Service Co-Director Anita Bhattacharyya, PhD
iPSC Service Co-Director
Andy Petersen, PhD Andy Petersen, PhD
Gene Editing Service Scientist

Yingnan Yin Yingnan Yin
iPSC Service Staff
Erich Berndt Erich Berndt
iPSC Service Staff